GlassScriptPhysician profile
Fares Sukhon
NPI 1962011833
$5,302.81
in general payments reported to CMS, 2019-2025
12 companies · $2,824 in 2025
The $2,824 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $259 · 2023: $873 · 2024: $1,346 · 2025: $2,824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,369 · Travel and Lodging: $1,113 · Education: $881 · Grant: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,368.99 |
| Travel and Lodging | $1,112.54 |
| Education | $880.82 |
| Grant | $681.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,906.31 | 2023-2025 | Corevalve Evolut R, Hawkone, Onyx Frontier |
| Abbott Laboratories | $1,047.87 | 2023-2025 | Ensite, Perclose Proglide, Amplatzer Talisman |
| Boston Scientific Corporation | $926.59 | 2024-2025 | General - Vascular Access |
| Philips North America LLC | $362.55 | 2024-2025 | Coronary Other, (Bh4) Igt Devices Undivided, (5028) Igt Devices Systems Undivided |
| Astrazeneca Pharmaceuticals LP | $227.80 | 2021 | |
| Abiomed | $216.65 | 2025 | |
| Penumbra, INC. | $143.00 | 2025 | Indigo System |
| Stryker Corporation | $116.95 | 2025 | Flowtriever |
| Edwards Lifesciences Corporation | $112.95 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Cardiva Medical, INC. | $111.78 | 2023 | Cardiva Vascade 6/7f Vcs |
| E.R. Squibb & Sons, L.L.C. | $98.70 | 2025 | Camzyos |
| Pfizer INC. | $31.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fares Sukhon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.